Monte Rosa Therapeutics (GLUE)
Monte Rosa Therapeutics (GLUE) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.
- GLUE last traded at $8.64 on 2026-11-20, -3.03% for the session.
- Monte Rosa Therapeutics: market cap $738.29M, revenue $70.33M over the last four quarters.
- Over the past year GLUE returned -38.90%, with a year-to-date return of -44.90%.